Randomized Clinical Trials: Prescriptions to Be Applied With Caution!
Open Access
- 1 May 2008
- journal article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 21 (5) , 483-484
Abstract
Randomized Clinical Trials (RCTs) accurately measure the relative health effects of medical interventions. Randomization and blinding protect against bias, both in assignment of treatment and in implementation, and eliminate confounding by known and, even more importantly, unrecognized, factors relating to the patients. RCTs are unsurpassed in their capacity to determine drug efficacy, and are an excellent first step in establishing drug safety. Justifiably, therefore, they have become a gold standard for clinical practice. But there are still aspects of clinical trials—particularly those that focus on blood pressure or diabetes—that should alert consumers to the need for caution before applying their results.Keywords
This publication has 4 references indexed in Scilit:
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugsJournal Of Hypertension, 2002
- Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with HypertensionNew England Journal of Medicine, 1991
- Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment.Hypertension, 1988